Literature DB >> 10901373

Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma.

R Kikuchi1, T Noguchi, S Takeno, N Kubo, Y Uchida.   

Abstract

We investigated whether the expression of membrane-type-1 matrix metalloproteinase (MT1-MMP), matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) was consistent with the proposed roles of these proteins in promoting metastasis in colorectal cancer. The expression of MT1-MMP was significantly more frequent in deeply invasive carcinomas (P = 0.007) and in cases of vascular invasion (P = 0.02). The frequency of detection of MMP-2 in the stroma was much greater in vascular invasion-positive cases (42%) than in negative cases (20%; P = 0.02). The rate of detection of TIMP-2 in tumour cell cytoplasm increased with the depth of invasion (P = 0.03). TIMP-2 in the stroma was found more frequently in tumours with lymphatic invasion and lymph node metastasis (P < 0.05). Significant correlations were found between detection of MT1-MMP and MMP-2 in tumour cell cytoplasm (P < 0.05), of MT1-MMP and TIMP-2 in tumour cell cytoplasm (P < 0.01), and of MMP-2 and TIMP-2 in tumour cell cytoplasm (P < 0.01). Immunohistochemical detection of MT1-MMP and TIMP-2 might be useful for monitoring infiltration in colorectal carcinoma but is not correlated with distant metastases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10901373      PMCID: PMC2363481          DOI: 10.1054/bjoc.2000.1195

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.

Authors:  I E Collier; S M Wilhelm; A Z Eisen; B L Marmer; G A Grant; J L Seltzer; A Kronberger; C S He; E A Bauer; G I Goldberg
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

Review 2.  Tumor cell interactions with the extracellular matrix during invasion and metastasis.

Authors:  W G Stetler-Stevenson; S Aznavoorian; L A Liotta
Journal:  Annu Rev Cell Biol       Date:  1993

3.  Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer.

Authors:  C Pyke; E Ralfkiaer; K Tryggvason; K Danø
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

4.  A matrix metalloproteinase expressed on the surface of invasive tumour cells.

Authors:  H Sato; T Takino; Y Okada; J Cao; A Shinagawa; E Yamamoto; M Seiki
Journal:  Nature       Date:  1994-07-07       Impact factor: 49.962

5.  Expression and activity of MMPS and their regulators in ovarian cancer.

Authors:  M S Naylor; G W Stamp; B D Davies; F R Balkwill
Journal:  Int J Cancer       Date:  1994-07-01       Impact factor: 7.396

Review 6.  Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis.

Authors:  W G Stetler-Stevenson; L A Liotta; D E Kleiner
Journal:  FASEB J       Date:  1993-12       Impact factor: 5.191

7.  A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies.

Authors:  N Fujimoto; N Mouri; K Iwata; E Ohuchi; Y Okada; T Hayakawa
Journal:  Clin Chim Acta       Date:  1993-11-30       Impact factor: 3.786

8.  Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies.

Authors:  M Höyhtyä; R Fridman; D Komarek; K Porter-Jordan; W G Stetler-Stevenson; L A Liotta; C M Liang
Journal:  Int J Cancer       Date:  1994-02-15       Impact factor: 7.396

9.  Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stage.

Authors:  P Ring; K Johansson; M Höyhtyä; K Rubin; G Lindmark
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Activity of type IV collagenases in benign and malignant breast disease.

Authors:  B Davies; D W Miles; L C Happerfield; M S Naylor; L G Bobrow; R D Rubens; F R Balkwill
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

View more
  20 in total

1.  Active matrix metalloproteinase-2 activity discriminates colonic mucosa, adenomas with and without high-grade dysplasia, and cancers.

Authors:  Mary Jo Murnane; Jinguo Cai; Sania Shuja; David McAneny; John B Willett
Journal:  Hum Pathol       Date:  2011-01-15       Impact factor: 3.466

2.  Targeting the MMP-14/MMP-2/integrin αvβ3 axis with multispecific N-TIMP2-based antagonists for cancer therapy.

Authors:  Gal Yosef; Valeria Arkadash; Niv Papo
Journal:  J Biol Chem       Date:  2018-07-09       Impact factor: 5.157

3.  Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.

Authors:  O Schwandner; A Schlamp; R Broll; H P Bruch
Journal:  Int J Colorectal Dis       Date:  2006-08-02       Impact factor: 2.571

4.  May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer?

Authors:  Bijayatha Shrestha; Dipshikha Bajracharya; Aditi Amit Byatnal; Asha Kamath; Raghu Radhakrishnan
Journal:  Pathol Oncol Res       Date:  2016-11-16       Impact factor: 3.201

5.  Correlation between the expression of the BAG-1 gene and clinicopathologic factors in colorectal cancer.

Authors:  Nian-Feng Sun; Qing-Yi Meng; San-Yuan Hu; Ai-Ling Tian; Rui-Hua Wang; Zhao-Xuan Liu; Li Xu
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-02       Impact factor: 4.553

6.  Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease.

Authors:  T Kirkegaard; A Hansen; E Bruun; J Brynskov
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

7.  Immunoexpression of metalloproteinases 2 and 14 and TIMP-2 inhibitor in main types of primary gastric carcinomas and lymph node metastasis.

Authors:  Daniel Cordeiro Gurgel; José Telmo Valença-Junior; Conceição Aparecida Dornelas; Renato Braga Vieira; João Tarcisio Alves Maia-Filho; Roberto Cesar Pereira Lima-Junior; Ronaldo Albuquerque Ribeiro; Paulo Roberto Carvalho Almeida
Journal:  Pathol Oncol Res       Date:  2014-05-07       Impact factor: 3.201

8.  New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.

Authors:  Laetitia Devy; Daniel T Dransfield
Journal:  Biochem Res Int       Date:  2010-10-28

9.  Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas.

Authors:  Elke Roeb; Marlies Arndt; Bettina Jansen; Volker Schumpelick; Siegfried Matern
Journal:  Int J Colorectal Dis       Date:  2004-04-22       Impact factor: 2.571

10.  Tissue inhibitor of matrix metalloproteinase-2 in nasopharyngeal carcinoma.

Authors:  Amr Ahmed El Badry; Amal Abou El-Fadle; Abdel Latif El-Balshy
Journal:  MedGenMed       Date:  2007-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.